227 related articles for article (PubMed ID: 14631126)
21. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
[TBL] [Abstract][Full Text] [Related]
22. Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism.
Huang CC; Yen TC; Shih TS; Chang HY; Chu NS
Neurotoxicology; 2004 Mar; 25(3):341-7. PubMed ID: 15019297
[TBL] [Abstract][Full Text] [Related]
23. Dopamine transporter binding in chronic manganese intoxication.
Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
[TBL] [Abstract][Full Text] [Related]
24. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
25. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
[TBL] [Abstract][Full Text] [Related]
27. Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.
Van Laere K; De Ceuninck L; Dom R; Van den Eynden J; Vanbilloen H; Cleynhens J; Dupont P; Bormans G; Verbruggen A; Mortelmans L
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1119-27. PubMed ID: 15064872
[TBL] [Abstract][Full Text] [Related]
28. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
29. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
Hu P; Chen L; Zhang HQ; Li JR; Liang H
Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
Boesch SM; Donnemiller E; Müller J; Seppi K; Weirich-Schwaiger H; Poewe W; Wenning GK
Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
[TBL] [Abstract][Full Text] [Related]
31. Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent.
Kung HF
Nucl Med Biol; 2001 Jul; 28(5):505-8. PubMed ID: 11516695
[TBL] [Abstract][Full Text] [Related]
32. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
[TBL] [Abstract][Full Text] [Related]
34. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
Kung HF; Kim HJ; Kung MP; Meegalla SK; Plössl K; Lee HK
Eur J Nucl Med; 1996 Nov; 23(11):1527-30. PubMed ID: 8854853
[TBL] [Abstract][Full Text] [Related]
35. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF
J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494
[TBL] [Abstract][Full Text] [Related]
36. (99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.
Wu YC; Peng GS; Cheng CA; Lin CC; Huang WS; Hsueh CJ; Lee JT
Ann Nucl Med; 2009 Jun; 23(4):409-12. PubMed ID: 19381760
[TBL] [Abstract][Full Text] [Related]
37. A new knock-in mouse model of l-DOPA-responsive dystonia.
Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
[TBL] [Abstract][Full Text] [Related]
38. Decreased dopamine transporter binding in Machado-Joseph disease.
Yen TC; Lu CS; Tzen KY; Wey SP; Chou YH; Weng YH; Kao PF; Ting G
J Nucl Med; 2000 Jun; 41(6):994-8. PubMed ID: 10855623
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous [99mTc]TRODAT-1 and [123I]ADAM brain SPECT in nonhuman primates.
Ma KH; Lee JK; Huang SY; Yeh CB; Shen YC; Shen LH; Chen CC; Liu RS; Liu JC; Huang WS
Mol Imaging Biol; 2009; 11(4):253-62. PubMed ID: 19225845
[TBL] [Abstract][Full Text] [Related]
40. Involvement of nigrostriatal pathway in Japanese encephalitis with movement disorders: evidence from 99mTc-TRODAT-1 and 123I-IBZM SPECT imagings.
Liao CH; Ling Z; Chou CH; Huang WS; Denq JC; Lin JC; Chen CY; Chang CJ; Peng GS
Mol Imaging Biol; 2010; 12(1):9-14. PubMed ID: 19548034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
